Literature DB >> 19959010

Therapeutic advances in malignant glioma: current status and future prospects.

H Ian Robins1, Andrew B Lassman, Deepak Khuntia.   

Abstract

This article reviews the current status and trends in the treatment of primary gliomas, focusing predominantly on glioblastoma. It also discusses the current standard of care and new targeted agents currently under investigation. Furthermore, the concepts of pseudoprogression and pseudoresponse are introduced, which are new imaging correlates that have significant impact on understanding of the disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19959010     DOI: 10.1016/j.nic.2009.08.015

Source DB:  PubMed          Journal:  Neuroimaging Clin N Am        ISSN: 1052-5149            Impact factor:   2.264


  6 in total

1.  Fluorescence lifetime imaging microscopy for brain tumor image-guided surgery.

Authors:  Yinghua Sun; Nisa Hatami; Matthew Yee; Jennifer Phipps; Daniel S Elson; Fredric Gorin; Rudolph J Schrot; Laura Marcu
Journal:  J Biomed Opt       Date:  2010 Sep-Oct       Impact factor: 3.170

2.  Fluorescence lifetime spectroscopy for guided therapy of brain tumors.

Authors:  Pramod V Butte; Adam N Mamelak; Miriam Nuno; Serguei I Bannykh; Keith L Black; Laura Marcu
Journal:  Neuroimage       Date:  2010-11-03       Impact factor: 6.556

3.  Fluorescence Lifetime Spectroscopy and Imaging in Neurosurgery.

Authors:  Laura Marcu; Brad A Hartl
Journal:  IEEE J Sel Top Quantum Electron       Date:  2012-01-24       Impact factor: 4.544

4.  Prognostic significance of kappaB-Ras1 expression in gliomas.

Authors:  Hong Lin; Yangang Wang; Xiang Zhang; Bolin Liu; Wei Zhang; Jinxiang Cheng
Journal:  Med Oncol       Date:  2011-02-08       Impact factor: 3.064

5.  Oxidative stress and PARP activation mediate the NADH-induced decrease in glioma cell survival.

Authors:  Yingxin Ma; Heyu Chen; Weiliang Xia; Weihai Ying
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2010-10-12

Review 6.  Treating recurrent glioblastoma: an update.

Authors:  Carlos Kamiya-Matsuoka; Mark R Gilbert
Journal:  CNS Oncol       Date:  2015
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.